Follow
Charles Craddock
Charles Craddock
Professor of Haemato-oncology, University of Warwick
Verified email at uhb.nhs.uk
Title
Cited by
Cited by
Year
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ...
Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022
11542022
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia
N Goardon, E Marchi, A Atzberger, L Quek, A Schuh, S Soneji, P Woll, ...
Cancer cell 19 (1), 138-152, 2011
7432011
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers
M Cobbold, N Khan, B Pourgheysari, S Tauro, D McDonald, H Osman, ...
The Journal of experimental medicine 202 (3), 379-386, 2005
6262005
The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.
T Papayannopoulou, C Craddock, B Nakamoto, GV Priestley, NS Wolf
Proceedings of the National Academy of Sciences 92 (21), 9647-9651, 1995
5971995
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
CA Bradbury, FL Khanim, R Hayden, CM Bunce, DA White, MT Drayson, ...
Leukemia 19 (10), 1751-1759, 2005
5202005
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia
AK Burnett, NH Russell, RK Hills, J Kell, S Freeman, L Kjeldsen, ...
J Clin Oncol 30 (32), 3924-3931, 2012
4532012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
OC Goodyear, M Dennis, NY Jilani, J Loke, S Siddique, G Ryan, ...
Blood, The Journal of the American Society of Hematology 119 (14), 3361-3369, 2012
4382012
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
S Chakrabarti, S Mackinnon, R Chopra, PD Kottaridis, K Peggs, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4357-4363, 2002
4302002
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
R Chakraverty, K Peggs, R Chopra, DW Milligan, PD Kottaridis, ...
Blood, The Journal of the American Society of Hematology 99 (3), 1071-1078, 2002
4002002
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
F Dazzi, RM Szydlo, C Craddock, NCP Cross, J Kaeda, A Chase, ...
Blood, The Journal of the American Society of Hematology 95 (1), 67-71, 2000
3932000
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid …
O Goodyear, A Agathanggelou, I Novitzky-Basso, S Siddique, ...
Blood, The Journal of the American Society of Hematology 116 (11), 1908-1918, 2010
3722010
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
K Cwynarski, J Ainsworth, M Cobbold, S Wagner, P Mahendra, J Apperley, ...
Blood, The Journal of the American Society of Hematology 97 (5), 1232-1240, 2001
3662001
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
KS Peggs, A Hunter, R Chopra, A Parker, P Mahendra, D Milligan, ...
The Lancet 365 (9475), 1934-1941, 2005
3472005
Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance
S Krishna, DW Waller, F Ter Kuile, D Kwiatkowski, J Crawley, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (1), 67-73, 1994
3261994
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
F Dazzi, RM Szydlo, NCP Cross, C Craddock, J Kaeda, E Kanfer, ...
Blood, The Journal of the American Society of Hematology 96 (8), 2712-2716, 2000
3222000
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris, K Thomson, C Craddock, P Mahendra, D Milligan, G Cook, ...
Blood 104 (13), 3865-3871, 2004
3212004
Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice
CF Craddock, B Nakamoto, RG Andrews, GV Priestley, ...
Blood, The Journal of the American Society of Hematology 90 (12), 4779-4788, 1997
3071997
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+ CD25high regulatory T cells
FJ Clark, R Gregg, K Piper, D Dunnion, L Freeman, M Griffiths, G Begum, ...
Blood 103 (6), 2410-2416, 2004
2842004
Clinical features and outcome of severe malaria in Gambian children
D Waller, S Krishna, J Crawley, K Miller, F Nosten, D Chapman, ...
Clinical infectious diseases 21 (3), 577-587, 1995
2761995
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in …
S Tauro, C Craddock, K Peggs, G Begum, P Mahendra, G Cook, J Marsh, ...
Journal of Clinical Oncology 23 (36), 9387-9393, 2005
2712005
The system can't perform the operation now. Try again later.
Articles 1–20